Who owns Paratek Pharmaceuticals?
- CUSIP Number: 699374302
Tip: Access positions for across all investors
Analyze quarterly positions in Paratek Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Paratek Pharmaceuticals stock
Who bought or sold Paratek Pharmaceuticals this quarter?
There are no current stakeholders of Paratek Pharmaceuticals.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Paratek Pharmaceuticals?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Eugene S. Stark | Jun 2023 | 1.8M | $4.1M |
Rock Springs Capital Management | Jun 2023 | 1.7M | $3.8M |
Eversept Partners | Jun 2023 | 1.3M | $2.9M |
BlackRock | Jun 2023 | 895k | $2.0M |
Natixis | Jun 2023 | 492k | $1.1M |
Geode Capital Management | Jun 2023 | 440k | $972k |
Gabelli Funds | Jun 2023 | 370k | $817k |
Hunting Hill Global Capital | Jun 2023 | 361k | $798k |
Gabelli Securities | Jun 2023 | 307k | $678k |
State Street Corporation | Jun 2023 | 216k | $478k |
Renaissance Technologies | Jun 2023 | 130k | $286k |
Trellus Management Company | Jun 2023 | 127k | $281k |
Susquehanna International | Jun 2023 | 118k | $261k |
Northern Trust | Jun 2023 | 114k | $253k |
Morgan Stanley | Jun 2023 | 111k | $246k |
Yakira Capital Management | Jun 2023 | 100k | $221k |
Water Island Capital | Jun 2023 | 85k | $187k |
XTX Topco | Jun 2023 | 63k | $139k |
Kathmere Capital Management | Jun 2023 | 30k | $66k |
Teton Advisors | Jun 2023 | 25k | $55k |
GAMCO Asset Management | Jun 2023 | 19k | $42k |
LPL Financial | Jun 2023 | 11k | $23k |
FMR | Jun 2023 | 420.00 | $927.990000 |